RIT Capital Partners (LON:RCP – Get Free Report) insider Cecilia McAnulty purchased 5,077 shares of the stock in a transaction dated Monday, April 29th. The stock was purchased at an average cost of GBX 1,969 ($24.73) per share, for a total transaction of £99,966.13 ($125,569.82).
RIT Capital Partners Stock Performance
Shares of LON:RCP opened at GBX 1,966 ($24.70) on Wednesday. RIT Capital Partners has a 1 year low of GBX 1,696 ($21.30) and a 1 year high of GBX 2,030 ($25.50). The firm has a market capitalization of £2.89 billion, a PE ratio of -1,337.41 and a beta of 0.45. The company has a debt-to-equity ratio of 10.62, a current ratio of 1.46 and a quick ratio of 1.06. The business’s 50 day moving average price is GBX 1,786 and its 200-day moving average price is GBX 1,802.59.
RIT Capital Partners Increases Dividend
The business also recently disclosed a dividend, which was paid on Friday, April 26th. Investors of record on Thursday, April 4th were given a dividend of GBX 19.50 ($0.24) per share. This is an increase from RIT Capital Partners’s previous dividend of $19.00. The ex-dividend date was Thursday, April 4th. This represents a yield of 1.1%. RIT Capital Partners’s dividend payout ratio (DPR) is presently -2,585.03%.
RIT Capital Partners Company Profile
RIT Capital Partners plc is a self-managed investment trust. The firm invests in the public equity and currency markets across the globe. It also invests in private investments and equity funds. The firm benchmarks the performance of its portfolio against the RPI plus 3% and MSCI All Country World Index (50% Sterling).
Read More
- Five stocks we like better than RIT Capital Partners
- Stock Market Sectors: What Are They and How Many Are There?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Buy Cheap Stocks Step by Step
- Hilton Demonstrates Asset Light is Right for Investors
- Health Care Stocks Explained: Why You Might Want to Invest
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for RIT Capital Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RIT Capital Partners and related companies with MarketBeat.com's FREE daily email newsletter.